Shares of Canopy Growth Corp (NASDAQ:CGC) are trading sharply higher Wednesday afternoon following news of a potential major shift in federal cannabis policy. Here’s what investors need to know.
- Canopy Growth stock is surging to new heights today. What’s driving CGC stock higher?
Trump Administration Expected To Announce Marijuana Reclassification
According to an administration official cited by Axios, the Trump administration is expected to reclassify marijuana as early as Wednesday. This highly anticipated development follows an executive order from the president last year to reclassify marijuana as a Schedule III drug.
This regulatory shift is a vital catalyst for Canopy Growth’s medical division and long-term growth strategy. The impending reclassification specifically eases U.S. Drug Enforcement Administration barriers to researching the drug’s potential use cases. For an industry leader like CGC with established infrastructure, the move would make it easier to study medicinal applications of marijuana.
This potentially allows Canopy Growth to aggressively expand its clinical research, validate its existing product pipelines, and potentially develop lucrative new medical cannabis treatments with significantly fewer federal hurdles.
Canopy Growth Stock Analysis: Navigating The 52-Week Range
Canopy Growth is trading in the middle of its 52-week range ($2.38 high, 84 cents low), which keeps the longer-term picture in “rebuild mode” rather than a clean breakout. The stock is trading 31.4% above its 20-day simple moving average (SMA) and 17.9% above its 100-day SMA, which leans toward short-term strength carrying into the intermediate trend.
The moving average backdrop is still mixed: the 20-day SMA remains below the 50-day SMA, and the death cross that formed in November 2025 (50-day SMA below the 200-day SMA) is a reminder the longer trend only recently started stabilizing. That said, price is now 11.3% above the 200-day SMA, which is consistent with buyers defending the longer-term line more aggressively.
The moving average convergence divergence (MACD), a trend/momentum measure, is above its signal line with a positive histogram, which points to improving upside momentum versus the prior downswing. When MACD stays above its signal, it often reflects rallies that are being “pushed” by follow-through buying rather than one-off spikes.
- Key Resistance: $1.50 — where recent rallies have tended to stall and sellers show up.
- Key Support: $1.00 — a key floor area where demand has previously appeared.
CGC Earnings Preview: Revenue, EPS Estimates
Looking further out, the next major catalyst for the stock arrives with the May 29 (estimated) earnings report.
- EPS Estimate: Loss of 6 cents (Up from $-1.01 YoY)
- Revenue Estimate: $53.26 million (Up from $45.75 million YoY)
CGC Shares Surge Wednesday Afternoon
CGC Stock Price Activity: Canopy Growth shares were up 18.42% at $1.35 at the time of publication on Wednesday, according to Benzinga Pro data.
Image: Shutterstock
Recent Comments